Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase

• References

• 1 Khosravi M. Candidate Psychotropics against SARS - CoV - 2: A Narrative Review. Pharmacopsychiatry 2021;
• 2 Tagashira H, Fukunaga K. Cardioprotective effect of fluvoxamine, sigma-1 receptor high affinity agonist. Yakugaku Zasshi 2012; 132: 167-172
• 3 Almási N, Török S, Dvorácskó S. et al. Lessons on the Sigma-1 Receptor in TNBS-Induced Rat Colitis: Modulation of the UCHL-1, IL-6 Pathway. Int J Mol Sci 2020; 21: 4046
• 4 Bhuiyan MS, Tagashira H, Fukunaga K. Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Eur J Pharmacol 2011; 650: 621-628
• 5 Ye T, Liu X, Qu C. et al. Chronic inhibition of the sigma-1 receptor exacerbates atrial fibrillation susceptibility in rats by promoting atrial remodeling. Life Sci 2019; 235: 116837
• 6 Åkerström S, Gunalan V, Keng CT. et al. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology 2009; 395: 1-9
• 7 Pourbagher-Shahri AM, Farkhondeh T, Talebi M. et al. An Overview of NO Signaling Pathways in Aging. Molecules 2021; 26: 4533
• 8 Vassiliou AG, Zacharis A, Keskinidou C. et al. Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS). Pharmaceuticals (Basel) 2021; 14: 695